Chicago Center for Vision Research

The Chicago Center for Vision Research (CCVR) is a non-profit research organization and 501(c)(3) corporation based in Chicago, Illinois, dedicated to advancing the study and treatment of glaucoma and other vision-threatening diseases. Founded in 1998 by a group of ophthalmologists from University Eye Specialists, the center serves as a hub for clinical research, professional education, and community outreach. CCVR is widely recognized for its sponsorship of the Low-pressure Glaucoma Treatment Study (LoGTS), a landmark clinical trial that evaluated the efficacy of various topical hypotensive medications such as Alphagan and Timoptic. The organization also supports specialized fellowships to train future glaucoma specialists in advanced surgical and diagnostic techniques. Through its collaborations with academic institutions like Northwestern University, CCVR aims to translate scientific discoveries into improved clinical outcomes for patients worldwide. Its mission encompasses both the development of innovative therapies and the provision of eye care services to underserved populations.